Risperidone (Brand: Risperdal).

The article offers guidelines on aspects of Risperidone which is in a class of medications called atypical antipsychotics. As stated, the said drug has indications approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and in adolescents who are aged 13 to 17. Some of the major potential risks and side effects of risperidone therapy are offered. Information about the dosage of the said drug is also provided.